Argitalpenak (65) LETICIA BAGAN DEBON argitalpenak

2024

  1. Clinical practice guideline of the Spanish society of oral surgery for dental care in patients with oral cancer

    Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 29, Núm. 1, pp. e67-e77

  2. Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features

    Oral Diseases, Vol. 30, Núm. 3, pp. 1072-1083

  3. Proliferative verrucous and homogeneous Leukoplakias exhibit differential methylation patterns

    Oral Diseases

2023

  1. Key features for the differential diagnosis of odontogenic pain through audiovisual support: Alternative learning methodologies

    Educacion Medica, Vol. 24, Núm. 5

  2. Manifestaciones en la mucosa oral de las enfermedades sistémicas

    Tratamiento odontológico en pacientes frágiles y con necesidades especiales (Laboratorios Normon), pp. 383-424

  3. On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  4. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 135, Núm. 3, pp. 385-395

  5. Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study

    Oral Diseases, Vol. 29, Núm. 5, pp. 2117-2129

2022

  1. Effect of clinical and histologic features on time to malignancy in 224 cases of oral leukoplakia treated by surgery

    Clinical Oral Investigations, Vol. 26, Núm. 8, pp. 5181-5188

  2. Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning

    Oral Oncology, Vol. 132

2021

  1. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma

    Oral Oncology, Vol. 116

  2. Guía de Práctica Clínica. Atención Odontológica al Paciente con Cáncer Oral

    Medicina Oral S.L.

  3. Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development

    Clinical Oral Investigations, Vol. 25, Núm. 5, pp. 2645-2657

  4. Medication‐related osteonecrosis of the jaw: A critical narrative review

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  5. Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens

    Oral Oncology, Vol. 120

  6. Recurrences following treatment of proliferative verrucous leukoplakia: A systematic review and meta-analysis

    Journal of Oral Pathology and Medicine, Vol. 50, Núm. 8, pp. 820-828

  7. Retraction: Oral leukoplakia, a clinical-histopathological study in 412 patients

    Journal of Clinical and Experimental Dentistry, Vol. 13, Núm. 5, pp. 26-32

  8. Stimulated whole salivary flow rate: The most appropriate technique for assessing salivary flow in sjögren syndrome

    Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 26, Núm. 3, pp. e404-e407

  9. The effectiveness of glutathione redox status as a possible tumor marker in colorectal cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

2020

  1. Association between maxillary sinus pathology and odontogenic lesions in patients evaluated by cone beam computed tomography. A systematic review and meta-analysis

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 25, Núm. 1, pp. 16